Substance
BICTEGRAVIR SODIUM
Global reference: every product and company linked to this substance.
- cas: 1807988-02-8
- ncit: C142955
- pubchem_cid: 102593990
- rxnorm: 1999661
- unii: 4L5MP1Y7W7
BICTEGRAVIR SODIUM [JAN] · BICTEGRAVIR SODIUM [USAN] · Bictegravir sodium [WHO-DD] · BIKTARVY COMPONENT BICTEGRAVIR SODIUM · GS-9883 SODIUM · GS-9883-01 SODIUM
Revenue by product (1)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| GILEAD SCIENCES INC. COMMON STOCK | BIKTARVY | Q2 2026 | $3.8B* |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (3)
- BIKTARVY · GILEAD SCIENCES INC. COMMON STOCK
- BIXLENVO · GILEAD SCIENCES INC. COMMON STOCK
- BIXLENVO SUNLENCA STARTER PACK (COPACKAGED) · GILEAD SCIENCES INC. COMMON STOCK